About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Study Urges Age Should Not Prevent Access to Transplants for MDS

by Kathy Jones on December 8, 2013 at 8:41 PM
Font : A-A+

 Study Urges Age Should Not Prevent Access to Transplants for MDS

A study from Dana-Farber Cancer Institute reveals that patients with myelodysplastic syndromes (MDS) who were as old as 74 fared as well with stem cell transplantation as did patients in the 60-to-65 age range. The research was presented at the annual meeting of the American Society of Hematology.

"This is good evidence that age alone should not limit who should get a transplant for MDS," said Gregory Abel, MD, MPH, a medical oncologist at Dana-Farber. "Calendar age is less important than other measures, such as whether a patient is physically fit enough to get through a transplant, has a lot of comorbidities, and what his or her performance status is."

Advertisement

MDS comprises several types of bone marrow failure causing severe anemia.

Abel, senior author Edwin P. Alyea, MD, and their colleagues analyzed the Dana-Farber experience over 10 years with reduced-intensity conditioning "mini-transplants" in patients with MDS, a group of bone-marrow disorders that generally develop in older adults. The mean age at diagnosis is 71.
Advertisement

Transplantation is the only potentially curative treatment for MDS in any age group, but many patients are not healthy enough to undergo the procedure.

The Dana-Farber researchers studied the records of 67 patients ranging in age from 60 to 74. The majority - 64 percent - received transplants from unrelated donors. Comparing recipients who were 60 to 65 with those older than 66, there were no statistically significant differences in overall survival at four years or in four-year survival without disease progression.

Patients in the two age groups also had comparable rates of deaths that weren't caused by disease relapse, and in the cumulative incidence of relapse itself. In addition, using significant components of the revised International Prognostic Scoring System (IPSS-R), the authors created a new risk score to predict four-year overall survival at time of transplantation. In two multivariable models, one that included the IPSS-R and another that included the new score, age was not a significant predictor of overall survival.

The study findings, said Abel, "are good news, since patients with MDS tend to be elderly and this is the only curative treatment at the moment for this disease."

"We hope this contributes to a growing body of evidence that treatment options should not be denied because of advanced age alone," said Alyea. "This is especially important in the older patients who have Medicare."
Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
Effect of Blood Group Type on COVID-19 Risk and Severity
Woman with Rare Spinal Cord Defect from Birth Sues Doctor
Toothache
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Aplastic Anemia 

Recommended Reading
Transplantation
Organ and tissue transplantation can give a second chance at life to thousands of people. Learn ......
Kidney Transplantation
Since the early times, the novel idea of transplanting tissues and other body parts from one ......
Bone Marrow Transplantation
Preferred Term is Hematopoietic stem cell transplantation. In this stem cell from bone marrow are .....
Aplastic Anemia
Aplastic anemia (AA) is a term that refers to a condition where the body fails to produce enough blo...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use